Skip to main content
. Author manuscript; available in PMC: 2007 Sep 19.
Published in final edited form as: AIDS Res Hum Retroviruses. 2006 Oct;22(10):968–978. doi: 10.1089/aid.2006.22.968

TABLE 1.

Samples, Collection Dates, Time Points, ART Therapy, Viral Load (VL), CD4 Counts, and Sampled Tissuesa

Sample name Nb (86) Collection date Time point ART therapy VL (RNA copies/mL) CD4 count (cells/mm3) Sampled tissue
101600P 21 16-Oct-00 T1 456,987 277 Plasma
112000P 20 20-Nov-00 T2 801,458 619 Plasma
112800P 5 28-Nov-00 T3 367,984 551 Plasma
112800C 5 28-Nov-00 T3 Plasma
121800P 4 18-Dec-00 T4 Zidovudine and lamivudine/nelfinavir 3,966 585 Plasma
121800C 3 18-Dec-00 T4 Zidovudine and lamivudine/nelfinavir Plasma
022201M 3 22-Feb-01 T5 Zidovudine and lamivudine/nelfinavir 7,011 638 PBMC
070201P 4 02-Jul-01 T6 Zidovudine and lamivudine/efavirenz 746 379 Plasma
070201C 4 02-Jul-01 T6 Zidovudine and lamivudine/efavirenz Plasma
100901P 3 09-Oct-01 T7 Zidovudine and lamivudine/efavirenz <400 633 Plasma
100901M 3 09-Oct-01 T7 Zidovudine and lamivudine/efavirenz PBMC
021202P 3 12-Feb-02 T8 Zidovudine and lamivudine/efavirenz <400 743 Plasma
021202M 3 12-Feb-02 T8 Zidovudine and lamivudine/efavirenz PBMC
060302P 3 03-Jun-02 T9 Zidovudine and lamivudine/efavirenz <775 615 Plasma
060302C 2 03-Jun-02 T9 Zidovudine and lamivudine/efavirenz Plasma
a

Samples are designated by blood collection date and a letter indicating whether the sequence was derived from PPT plasma (P), CPT plasma (C), or PBMC (M), followed by a clone number. For example, 101600P1 is a sequence from October 16, 2000 isolated from PPT plasma and is clone number 1. Infection date for this trial participant was estimated as September 21, 2000. PPT and CPT are different plasma preparation tubes. PBMC, peripheral blood mononuclear cells.

b

N, the number of sequences for each time point; the number in parentheses indicates the total number of sequences.